These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9870646)

  • 1. The effect of ramatroban (BAY u 3405), a thromboxane A2 receptor antagonist, on nasal cavity volume and minimum cross-sectional area and nasal mucosal hemodynamics after nasal mucosal allergen challenge in patients with perennial allergic rhinitis.
    Terada N; Yamakoshi T; Hasegawa M; Tanikawa H; Maesako K; Ishikawa K; Konno A
    Acta Otolaryngol Suppl; 1998; 537():32-7. PubMed ID: 9870646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ramatroban (Baynas): a review of its pharmacological and clinical profile].
    Motobayashi Y; Imagawa W; Saida K
    Nihon Yakurigaku Zasshi; 2001 Dec; 118(6):397-402. PubMed ID: 11778458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of thromboxane A2 receptor antagonist (Bay u 3405) on nasal symptoms after antigen challenge in sensitized guinea pigs.
    Narita S; Asakura K; Kataura A
    Int Arch Allergy Immunol; 1996 Feb; 109(2):161-6. PubMed ID: 8563491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ramatroban (BAY u 3405): a novel dual antagonist of TXA2 receptor and CRTh2, a newly identified prostaglandin D2 receptor.
    Ishizuka T; Matsui T; Okamoto Y; Ohta A; Shichijo M
    Cardiovasc Drug Rev; 2004; 22(2):71-90. PubMed ID: 15179446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic effects of the histamine H1 receptor antagonist epinastine and the dual thromboxane A2 receptor and chemoattractant receptor-homologous molecule expressed on Th2 cells antagonist ramatroban on allergic rhinitis model in mice.
    Suzuki Y; Inoue T; Yamamoto A; Sugimoto Y
    Biol Pharm Bull; 2011; 34(4):507-10. PubMed ID: 21467637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of thromboxane A2 antagonist reduction in the treatment of patients with perennial allergic rhinitis].
    Narita S; Shirasaki H; Itoh J; Kobayashi K; Himi T
    Arerugi; 2004 Jun; 53(6):601-4. PubMed ID: 15247523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acoustic rhinometry, rhinomanometry and the amount of nasal secretion in the clinical monitoring of the nasal provocation test.
    Pirilä T; Nuutinen J
    Clin Exp Allergy; 1998 Apr; 28(4):468-77. PubMed ID: 9641574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of BAY u 3405, a thromboxane receptor antagonist, on prostaglandin D2-induced nasal blockage.
    Johnston SL; Smith S; Harrison J; Ritter W; Howarth PH
    J Allergy Clin Immunol; 1993 Apr; 91(4):903-9. PubMed ID: 8473679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasal passage patency in patients with allergic rhinitis measured by acoustic rhinometry: nasal responses after allergen and histamine provocation.
    Miyahara Y; Ukai K; Yamagiwa M; Ohkawa C; Sakakura Y
    Auris Nasus Larynx; 1998 Sep; 25(3):261-7. PubMed ID: 9799992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acoustic rhinometry: measuring the early and late phase of allergic immediate reaction in allergic rhinitis].
    Rasp G
    Laryngorhinootologie; 1993 Mar; 72(3):125-30. PubMed ID: 8471095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Power Doppler and B-mode sonography of nasal mucosa].
    Tasman AJ; Soor A; Helbig M; Frey H; Meuser J
    HNO; 1998 Apr; 46(4):332-8. PubMed ID: 9606647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasal mucosal blood flow after intranasal allergen challenge.
    Holmberg K; Bake B; Pipkorn U
    J Allergy Clin Immunol; 1988 Mar; 81(3):541-7. PubMed ID: 3346485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasal conditioning in perennial allergic rhinitis after nasal allergen challenge.
    Rozsasi A; Leiacker R; Keck T
    Clin Exp Allergy; 2004 Jul; 34(7):1099-104. PubMed ID: 15248856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in the nasal mucosal microvascular with allergic rhinitis].
    Chen S
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1992; 27(1):39-40, 62. PubMed ID: 1591041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of vascular reflex in nasal mucosal swelling in nasal allergy.
    Numata T; Konno A; Terada N; Hanazawa T; Nagata H; Tanikawa H
    Laryngoscope; 2000 Feb; 110(2 Pt 1):297-302. PubMed ID: 10680933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study of the antithrombotic effect of aspirin and Bay U3405, antagonist of a thromboxane A2 receptor].
    Cissé-Thiam M; Drouet L
    Dakar Med; 1999; 44(1):25-7. PubMed ID: 10797981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 2nd communication: distribution to organs and tissues in male, female and pregnant rats, and characteristics of protein binding in plasma.
    Steinke W; Ahr HJ; Hirayama M
    Arzneimittelforschung; 1997 Aug; 47(8):939-48. PubMed ID: 9296280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acoustic rhinometry in the study of the acute nasal allergic response.
    Lane AP; Zweiman B; Lanza DC; Swift D; Doty R; Dhong HJ; Kennedy DW
    Ann Otol Rhinol Laryngol; 1996 Oct; 105(10):811-8. PubMed ID: 8865777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of topical levocabastine on nasal response to allergen challenge and nasal hyperreactivity in perennial rhinitis.
    de Graaf-in 't Veld T; Garrelds IM; van Toorenenbergen AW; Mulder PG; Gerth van Wijk R; Boegheim JP
    Ann Allergy Asthma Immunol; 1995 Sep; 75(3):261-6. PubMed ID: 7552929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of allergen provocation on the nasal cycle estimated by acoustic rhinometry.
    Kim JK; Cho JH; Jang HJ; Shim DB; Shin HA
    Acta Otolaryngol; 2006 Apr; 126(4):390-5. PubMed ID: 16608791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.